SeaStar Medical, a healthcare company specializing in treatments for critically ill patients with organ failure, will announce its Q3 2026 financial results on November 11, 2026. The company will host a webcast and conference call to discuss its financial performance and business progress. SeaStar Medical's key product, QUELIMMUNE, is FDA-approved for treating acute kidney injury in critically ill pediatric patients, and the company is conducting pivotal trials for its SCD therapy in adults. Investors can register to attend the live call and access replays afterward.
SeaStar Medical's upcoming Q3 2026 financial results provide context for healthcare sector activity on Pluang. As of November 4, 2026, 121 of 150 priced health-sector US stocks rose while 23 fell. Notable movers include Medline Inc. Class A Common Stock at USD 37.50 with a 10.00% increase, Nuwellis Inc at USD 5.32 down 9.98%, and Oscar Health Inc at USD 35.20 up 8.61%.
Kelly Technology + Motion Recruitment, a division of Kelly Services, has been recognized as a Leader on Everest Group's 2026 U.S. IT Contingent Talent and Strategic Solutions PEAK Matrix® for its expertise in specialized IT staffing, consulting, and ...
Sutro Biopharma, a clinical-stage oncology company specializing in antibody drug conjugates (ADCs), announced its participation in several investor conferences in November and December 2026, including events hosted by Stifel, Truist Securities, UBS, ...
etoro has agreed to acquire LB Finanzas, a leading Argentine all-in-one financial app, to strengthen its presence in Latin America's fast-growing fintech market. LB Finanzas offers integrated investing and payment solutions, catering to Argentine ret...
JD.com announced it will publish its unaudited financial results for the third quarter of 2026 on November 17, before the U.S. market opens. The company's management will hold a conference call the same day to discuss the results, providing investors...
KE Holdings Inc., a major online and offline housing platform in China, will announce its unaudited financial results for the third quarter of 2026 on November 16 before the U.S. market opens. The company will host an earnings conference call at 7:00...
